AliveCor
- Company typePrivate
- Founded2010
- HeadquartersMountain View, United States
- Headcount101–250
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
AliveCor firmographics
Firmographics- Name
- AliveCor
- Legal name
- AliveCor, Inc.
- Website
- https://alivecor.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
AliveCor industry classification
Industry- Product category
- Cardiac Diagnostic Devices and AI ECG Platform
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals (334515)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- Cardiology Telemedicine Platforms (HLALAGAB), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where AliveCor is headquartered
LocationHeadquarters
- HQ city
- Mountain View
- HQ country
- United States
- HQ region
- North America
Markets served
AliveCor business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
AliveCor product offering
Product offeringCore offering
AliveCor develops and sells AI-powered ECG hardware devices (consumer KardiaMobile line and clinical Kardia 12L) paired with FDA-cleared deep neural network algorithms (Kardia AI V2, KAI 12L, Corvair) that interpret cardiac data. The company also operates enterprise software (KardiaPro), a virtual Center of Excellence cardiac care service (KardiaComplete), a consumer subscription (KardiaCare Plus), and an API/SDK that enables OEMs to embed its ECG AI into third-party devices and applications.
Product overview
AliveCor offers a platform-plus-modules architecture for AI-powered cardiac care, spanning consumer, clinical, and OEM segments. The core platform is the Kardia App paired with Kardia AI (including Kardia AI V2, KAI 12L, and Corvair algorithms) and the AliveCorCloud, which together interpret ECG signals and serve as the foundation for the broader product line. Consumer hardware modules include KardiaMobile (single-lead), KardiaMobile Card, KardiaMobile 6L, and the KardiaMobile 6L Max (with the KardiaAlert feature), all of which feed ECGs into the Kardia App. Clinical modules include the Kardia 12L 12-lead ECG system and the K1000 (InstantQT) point-of-care ECG, while the KardiaStation module supports in-clinic ECG workflows. Enterprise modules include KardiaPro (clinician platform for population-level ECG insights) and KardiaComplete Virtual Center of Excellence, which orchestrates end-to-end remote cardiac care delivery. The consumer-facing KardiaCare Plus subscription wraps these capabilities for at-home users. Finally, the API & SDK Solutions module enables OEM partners to embed AliveCor's FDA-cleared ECG AI into their own devices and applications.
Differentiator
Problem solved
Functional benefit
Brands
- Kardia 12L: AI-powered handheld 12-lead ECG system with single-cable, five-electrode design for healthcare professionals.
- KardiaMobile 6L
- KardiaMobile
- KardiaMobile Card
- KardiaPro
- KardiaStation
- KardiaComplete
- KardiaCare Plus
- K1000 (InstantQT)
Products and services
- Kardia 12L AI-assisted 12-lead ECG system for healthcare professionals. It is the first AI-powered 12-lead personal/clinical ECG platform, FDA-cleared in June 2024, CE-Marked in April 2026, and expanded into India (2025) and Vietnam (2026).
- KardiaMobile 6L Max Enhanced personal 6-lead ECG device for consumer at-home cardiac monitoring, capturing six leads of cardiac data and pairing with the Kardia app for AI-interpreted results.
- KardiaMobile 6L Personal 6-lead ECG device for consumer use that records medical-grade six-lead ECGs and transmits them to the Kardia app for AI-based interpretation.
- KardiaMobile Personal single-lead ECG device for consumer at-home cardiac monitoring, paired with the Kardia app for AI interpretation.
- KardiaMobile Card Card-format personal single-lead ECG device sold to consumers for portable at-home cardiac monitoring via the Kardia app.
- K1000 (InstantQT)
- Kardia App Companion mobile application that captures, displays, and analyzes ECGs from Kardia hardware devices, provides AI interpretations, integrates with Apple Health and Google Fit, and includes the AskKardia AI assistant.
- KardiaPro Enterprise platform for healthcare providers offering real-time heart rhythm analysis, population-level ECG insights, and clinician workflow integration.
- KardiaStation Point-of-care ECG software for clinical settings, enabling in-clinic ECG capture and AI interpretation within healthcare provider workflows.
- KardiaComplete (Virtual Center of Excellence) End-to-end remote cardiac care service that combines Kardia devices, AI interpretation, and clinician review to deliver a virtual Center of Excellence for cardiac monitoring and care, sold to payers, employers, and consultants on a PEPM basis.
- KardiaCare Plus Subscription-based heart health membership for Kardia device users, providing expanded cardiac reporting, expert reviews, and access to KardiaComplete services.
- API & SDK Solutions Developer-facing API and SDK offering that allows OEM partners and third-party developers to securely pull, analyze, and display ECG results using AliveCor's FDA-cleared AI algorithms, embed ECG technology into their own applications and devices, and leverage the 250M+ ECG database.
Companies that use AliveCor
Customer profileIdeal customer profiles6 records
AliveCor technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability8 records
AliveCor partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights6 records
AliveCor competitors and assessment
Company assessmentEmerging players
- HeartBeam: Early commercial-stage company developing a credit-card-sized 3D ECG device for at-home detection of heart attacks, with FDA-cleared synthesis software. Comparable emerging player in compact AI-ECG hardware and remote cardiac diagnostics.
Direct peers
- Eko Health: AI-powered digital stethoscope and cardiac auscultation/ECG platform with FDA-cleared algorithms and an enterprise provider channel. Closely comparable to AliveCor on AI-ECG technology, clinical-grade hardware, and provider/payer sales motion.
- Withings: Consumer health hardware maker offering ScanWatch and other devices with on-wrist ECG and cardiac monitoring integrated into a consumer health app. Directly comparable to AliveCor's KardiaMobile line in consumer-grade personal ECG hardware and consumer subscription model.
- iRhythm Technologies: Public digital health company (Zio long-term continuous monitoring patch) offering AI-interpreted ambulatory cardiac monitoring with FDA-cleared algorithms. Directly comparable to AliveCor in AI-ECG interpretation, clinical cardiology customers, and reimbursement-driven go-to-market.
Broad incumbents
- Philips (Cardiac Monitoring): Global medtech incumbent with a broad cardiac monitoring portfolio (including wearable ECG and inpatient telemetry) and AI-enabled cardiology analytics. Comparable to AliveCor at the clinical/enterprise tier where it competes for hospital and health system cardiac monitoring budgets.
- GE Healthcare: Lead investor in AliveCor's Series F and a global medtech incumbent with cardiac diagnostics, patient monitoring, and AI imaging. A channel partner and investor, but also a broad incumbent whose cardiology portfolio overlaps AliveCor's clinical footprint at health systems.
- Preventice Solutions (Boston Scientific): Acquired by Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring (MCOT) with AI-assisted arrhythmia detection. Comparable to AliveCor in remote cardiac monitoring services and enterprise/payer GTM.
- Apple (Apple Watch ECG): Apple Watch ships a built-in single-lead ECG feature integrated with iOS/Apple Health, the largest direct consumer ECG distribution channel. A broad incumbent comparable to AliveCor on consumer ECG experience and a key antagonist in the recent AliveCor antitrust dispute.
- Bardy Diagnostics (Baxter / Hillrom): Acquired by Hillrom (now Baxter), Bardy's CAM patch is a single-patient-use ambulatory ECG monitor with AI analysis. Comparable to AliveCor in patch/ambulatory AI-ECG and is now part of a large medtech portfolio competing for the same clinical accounts.
Others
- Omron Healthcare: Investor and commercial partner in AliveCor (Series C and Series E participant) and a global leader in consumer and clinical cardiovascular monitoring (blood pressure, ECG). Comparable as a strategic ecosystem participant and channel partner, not a direct AI-ECG competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AliveCor social profiles
Digital presenceAliveCor compliance and trust
Trust signalCompliance5 records
AliveCor financial estimates
Financial estimateRevenue estimate
Valuation estimate
AliveCor leadership team
Management profileNumber of profiles
Profiles14 records
AliveCor subsidiaries and ownership
Company hierarchySubsidiaries4 records
AliveCor funding detail
Funding detailFunding overview
Funding rounds8 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AliveCor M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AliveCor
What does AliveCor do?
AliveCor develops and sells AI-powered ECG hardware devices (consumer KardiaMobile line and clinical Kardia 12L) paired with FDA-cleared deep neural network algorithms (Kardia AI V2, KAI 12L, Corvair) that interpret cardiac data. The company also operates enterprise software (KardiaPro), a virtual Center of Excellence cardiac care service (KardiaComplete), a consumer subscription (KardiaCare Plus), and an API/SDK that enables OEMs to embed its ECG AI into third-party devices and applications.
Is AliveCor a public or private company?
AliveCor is a private company. It is classified as venture growth investor backed and is currently operating.
When was AliveCor founded?
AliveCor was founded in 2010. It employs 101 to 250 people.
Where is AliveCor based?
AliveCor is headquartered in Mountain View, United States, in the North America region.
Who are AliveCor's main competitors?
HeartBeam is listed as an emerging player. Direct peers are Eko Health, Withings and iRhythm Technologies. Broad incumbents are Philips (Cardiac Monitoring), GE Healthcare, Preventice Solutions (Boston Scientific), Apple (Apple Watch ECG) and Bardy Diagnostics (Baxter / Hillrom). Omron Healthcare is listed as an others.
Does AliveCor have an API?
Yes. AliveCor offers API and SDK Solutions enabling OEM partners and third-party developers to securely pull, analyze, and display ECG results using AliveCor's FDA-cleared AI algorithms. The APIs allow data storage and retrieval from the AliveCor cloud and are used by OEM partners to embed AliveCor's ECG technology into their own applications and devices. The SDK also enables third-party apps to leverage the 250M+ ECGs collected by AliveCor.
What industry is AliveCor in?
AliveCor's product category is Cardiac Diagnostic Devices and AI ECG Platform. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.